Oncology & Hematology Clinical Trial Development

Clinical trials for targeted oncology and hematology therapies have become incredibly complex in the world of precision medicine. Whether you need support with early phase adaptive trial design, site selection, patient identification or targeted services for late-phase oncology trials, partner with a CRO, focused on oncology, who can enable you to improve the health and lives of those who desperately need it. 


EARLY PHASE Oncology Trials

Basket, platform or umbrella adaptive trials

Whether you are considering a basket, platform or umbrella oncology trial to examine solid tumors or hematologic malignancies, move away from traditional oncology trial designs to incorporate more creative and adaptive trials. 

Early precision medicine and immunotherapy

Working with gene and cell therapies, such as cell-based immunotherapies and CAR T-cell requires a multi-pronged approach that goes beyond traditional clinical trials. From discovery to market, you can apply biomarker identification strategies, companion diagnostics, multi-level stratification designs and composite endpoints. 

LATE PHASE Oncology Trials

Targeted patient recruitment & site data

Leverage our experience with more than 140 immuno-oncology studies, including innovative CAR T studies. Then use our proprietary data tools to select high-performing oncology sites, engage investors, evaluate protocol design and geographically map potential oncology and immuno-oncology participants.

Data-driven trial oversight & management

More than 90% of our Phase II & III oncology trials are delivered on-time in study startup. You’ll get access to novel technologies like Xcellerate Monitoring that helps proactively safeguard patient safety and improve data quality as well as Xcellerate Insights that gives you a secure, shared view of your oncology trial’s latest operational metrics. And you can rely on a team of project managers and regulatory leaders to help you meet milestones. Finally, leverage our established relationships with oncology investigators, local and international key opinion leaders (KOLs), global collaborative groups and patient networks to help your cancer trial run efficiently. 

Oncology Scientific Network

Rely on the Covance Scientific Network to optimize your cancer trial. The network combines expertise, speed and quality to help you reduce startup times and decrease time to enrollment. On average, our clients experience a . . . 

  • 25-30% reduction for startup times
  • Decrease in time-to-first-patient as well as total trial enrollment
Optimizing recruitment for an oncology clinical trial